Sedative raises Alzheimer’s risk: Study

A popular sedative has been linked with an increased risk of developing Alzheimer’s disease.

Benzodiazepines, which are widely prescribed to treat anxiety and insomnia, have been associated with a heightened risk of developing the condition, particularly for long-term users, a new study suggests.

Researchers cautioned that unwarranted long-term use of the drugs should be considered a public health concern.

You have reached your article limit. Already a subscriber? Sign in

Unlimited access starts here.

Try from only €0.25 a day.

Cancel anytime

More in this section

Lunchtime News

Newsletter

Get a lunch briefing straight to your inbox at noon daily. Also be the first to know with our occasional Breaking News emails.

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited